公开(公告)号：US20250058020A1

公开(公告)日：2025-02-20

申请号：US18807099

申请日：2024-08-16

Applicant: Boston Scientific Scimed, Inc.

Inventor： Robert COUGHLAN ,  Mark LOONEY ,  Patrick NUGENT ,  Edward Joseph DEVLIN ,  John MURPHY ,  Megan CHROBAK ,  Darragh O’DONOVAN ,  Conor O’SULLIVAN

IPC: A61L27/24 ,  A61L27/18 ,  A61L27/52 ,  A61L27/58

Abstract: The present disclosure includes kits, compositions, and methods useful in medical procedures, such as treating a fistula or other target site of a subject. In some examples, the kit may comprise a dry particulate mixture, a first pharmaceutically acceptable buffer solution having a pH ranging from about 3 to about 5, and a second pharmaceutically acceptable buffer solution having a pH ranging from about 9 to about 11. The dry particulate mixture may comprise a plurality of polyethylene glycol particles and a plurality of collagen particles.